Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon
about
In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCGComplexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in TuberculosisTuberculosis vaccine types and timingsQuest for correlates of protection against tuberculosisRisk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsTranscriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers.M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice.Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4⁺ T cells and peripheral blood from tuberculosis patientsThe M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection.Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.Interaction of Pattern Recognition Receptors with Mycobacterium TuberculosisEvidence for a role for interleukin-17, Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaquesIn-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infantsRegulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection.Immunomodulation by vitamin D: implications for TB.Impaired M. tuberculosis Antigen-Specific IFN-γ Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary TuberculosisMultifunctional CD4 T cell responses in patients with active tuberculosis.IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDSA Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates.Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype.Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.Vaccine-mediated immunity to experimental Mycobacterium tuberculosis is not impaired in the absence of Toll-like receptor 9HIV Skews the Lineage-Defining Transcriptional Profile of Mycobacterium tuberculosis-Specific CD4+ T Cells.Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidatesDecreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10Contribution of interleukin-12 p35 (IL-12p35) and IL-12p40 to protective immunity and pathology in mice infected with Chlamydia muridarum.Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lungTowards a Chlamydia trachomatis vaccine: how close are we?Current investigational drugs in psoriasis.Protection versus pathology in tuberculosis: recent insights.Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.Involvement of IL-17A-producing TCR γδ T cells in late protective immunity against pulmonary Mycobacterium tuberculosis infectionGene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model.Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.Modulation of Roquin Function in Myeloid Cells Reduces Mycobacterium tuberculosis-Induced Inflammation.Expression pattern of transcription factors and intracellular cytokines reveals that clinically cured tuberculosis is accompanied by an increase in Mycobacterium-specific Th1, Th2, and Th17 cells.Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells.Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge.
P2860
Q24599551-59DFDCED-2569-467B-9774-4F618B9D064DQ26779956-6D3402D4-AFBD-488A-8593-318F3A87E2C9Q26862762-0742B217-22AA-4E0D-B299-8F029CF91CE1Q28084282-9C24F893-BFEA-4F2B-BA6D-AA91654A5E29Q33809045-8312B296-CCCB-4D0D-84E3-B9A7FE1DCBE0Q34168041-48B661EF-BD2C-40E0-B1D1-B0338B76ADFEQ34287451-5803FBEB-A277-4DCE-A51F-FA3397A08D44Q34484151-542201B9-CD5F-4E82-8848-71D06728EC34Q34603687-9CE326D9-DEB3-4739-9549-E6B7D363D572Q34684639-6AA24343-B826-4B57-91E9-2FF236F12497Q34983762-C863D409-DAC8-4553-BB1A-8D7A98041EA5Q34986921-F9F75260-CBFB-46F3-9598-672A05E931DDQ35014476-CE3AFA3C-9E1E-4F65-AC16-49AB778CE096Q35088532-5B9E78CA-8F98-4576-92FC-A12BADB176BDQ35097422-F0F930F5-95B8-462C-8D79-7F6032262E7EQ35441389-00DAF1E8-5DA2-4B2B-8AC1-B6EDFC93D04BQ35447373-C484A931-67EF-4313-B795-A7782FDAD043Q35643864-DFAE24DE-21CB-41B5-9B4D-30D26E4A0743Q35661020-408E12EA-56E5-42E3-91F8-2735EE1CCC5BQ35784621-A375E1BC-567B-4399-958E-C3BF38F3470FQ35849628-EC21FAC9-BA42-4970-A861-8D6838C756B7Q35988556-843F8FC5-A5E0-4DE3-9569-115CAD5A972FQ36277359-7B97CC71-EF8B-4C73-8707-DE69E389D4DAQ36689438-5803C65E-F836-401B-A2B9-BCE06032CCE5Q36706314-37A4BEC9-9518-4856-A9D8-5D9931879740Q36909492-70CC40BE-6648-442E-8A42-1C8FCF2C4D78Q37015140-75B6BCA9-7D3F-49BF-8C2E-2E3638AA0B07Q37036053-18947117-C558-4B2C-9F0E-A7534574102CQ37666257-DB3B209A-5190-4F6A-90C9-8201252BEFF0Q37820669-402DC5B5-23B5-47D8-B08F-F2D164F07764Q37991748-E856D63D-8817-413D-B78D-6C7985A7741CQ38011865-35D33BE0-EFAD-4441-9F52-5696C7414404Q38031924-6E0B707C-1D23-4869-AD0B-44D55F6BD636Q39096613-0540C9E4-75C8-4936-A0A4-F9E3269D4531Q39497862-014BFD5C-1B2B-4E50-944B-08D615DE1809Q40109877-50207580-68BE-4C1B-9FA4-354D71DAED95Q40118455-E87CA3DE-AA9E-430E-9217-803FF7E9F609Q40524081-D2468014-550F-489B-A436-81F4AF1090F6Q41021544-81FD2A50-C79B-4E24-B51E-3856CFD29A0DQ41517191-800077CD-47F6-42C4-A6F5-750F6F15F20B
P2860
Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@ast
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@en
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@nl
type
label
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@ast
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@en
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@nl
prefLabel
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@ast
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@en
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@nl
P2093
P2860
P356
P1476
Mycobacterium bovis BCG-specif ...... he absence of gamma interferon
@en
P2093
Anthony A Ryan
Bernadette M Saunders
Teresa M Wozniak
Warwick J Britton
P2860
P304
P356
10.1128/IAI.01392-09
P407
P577
2010-08-02T00:00:00Z